-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EW8Ele8kOIe4HTn6/SSWzJoYyUkCuQUwBUFwD5+zn7R8AZO5FKmBJAn+7hszxt6a NiMk+ff3Z22XkGALB+ejGg== 0001181431-06-013955.txt : 20060223 0001181431-06-013955.hdr.sgml : 20060223 20060223190113 ACCESSION NUMBER: 0001181431-06-013955 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060221 FILED AS OF DATE: 20060223 DATE AS OF CHANGE: 20060223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LINSLEY ERIC W CENTRAL INDEX KEY: 0001320179 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24241 FILM NUMBER: 06640710 BUSINESS ADDRESS: BUSINESS PHONE: 9199983300 MAIL ADDRESS: STREET 1: 7030 KIT CREEK ROAD STREET 2: P.O. BOX 110287 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PANACOS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001040017 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 113238476 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 134 COOLIDGE AVE CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-926-1551 MAIL ADDRESS: STREET 1: 134 COOLIDGE AVE CITY: WATERTOWN STATE: MA ZIP: 02472 FORMER COMPANY: FORMER CONFORMED NAME: V I TECHNOLOGIES INC DATE OF NAME CHANGE: 19980209 4 1 rrd109208.xml FORM 4 FOR 2/21/2006 X0202 4 2006-02-21 0 0001040017 PANACOS PHARMACEUTICALS, INC. PANC 0001320179 LINSLEY ERIC W A.M. PAPPAS & ASSOCIATES, LLC 7030 KIT CREEK ROAD RESEARCH TRIANGLE PARK NC 27709 1 0 0 0 Common stock 2006-02-21 4 J 0 900000 0.0 D 1763305 I See footnote 1 Common stock 2006-02-21 4 J 0 95971 0.0 A 95971 I See footnote 1 Common stock 2006-02-21 4 S 0 48000 7.316 D 47971 I See footnote 5 Common stock 2006-02-21 4 J 0 22494 0.0 A 22494 D Common stock 2006-02-21 4 S 0 22494 7.48 D 0 D Common stock 2754 D On February 21, 2006, A.M. Pappas Life Science Ventures I, L.P. (the "Fund") made a distribution of 900,000 shares of Panacos Pharmaceuticals, Inc. to its partners for no consideration. The reporting person received 2,209 shares. A.M. Pappas & Associates, LLC ("AMP&A") received 95,971 shares. 1,763,305 shares are directly held by the Fund, which has a general partner, AMP&A Management, LLC ("Management"), which is managed by AMP&A. AMP&A may be deemed a beneficial owner of these securities. The reporting person is a member of AMP&A and, as a result, may also be deemed a beneficial owner of these securities. The reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that this person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. In addition to receiving 2,209 shares from the Fund, 20,285 shares were received in a distribution from Management on February 21, 2006. These shares were received for no consideration. This per share price represents the average sales price per share that the reporting person received on all trades. This per share price represents the average sales price per share that the entity received on all trades. On February 21, 2006, AMP&A received 95,971 shares from the Fund and sold 48,000 of these shares. /s/ Eric E. Linsley 2005-02-23 -----END PRIVACY-ENHANCED MESSAGE-----